{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:18:38Z","timestamp":1792001918124,"version":"4.4.0"},"reference-count":83,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Thymic epithelial tumors (TETs) are characterized by their extreme rarity and variable clinical presentation, with the inadequacy of the use of histological classification alone to distinguish biologically indolent from aggressive cases. The utilization of Next Generation Sequencing (NGS) to unravel the intricate genetic landscape of TETs could offer us a comprehensive understanding that is crucial for precise diagnoses, prognoses, and potential therapeutic strategies. Despite the low tumor mutational burden of TETS, NGS allows for exploration of specific genetic signatures contributing to TET onset and progression. Thymomas exhibit a limited mutational load, with prevalent GTF2I and HRAS mutations. On the other hand, thymic carcinomas (TCs) exhibit an elevated mutational burden, marked by frequent mutations in TP53 and genes associated with epigenetic regulation. Moreover, signaling pathway analyses highlight dysregulation in crucial cellular functions and pathways. Targeted therapies, and ongoing clinical trials show promising results, addressing challenges rooted in the scarcity of actionable mutations and limited genomic understanding. International collaborations and data-sharing initiatives are crucial for breakthroughs in TETs research.<\/jats:p>","DOI":"10.3390\/ijms25031554","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T08:56:01Z","timestamp":1706259361000},"page":"1554","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Molecular Landscape of Thymic Epithelial Tumors: A Comprehensive Review"],"prefix":"10.3390","volume":"25","author":[{"given":"Lisa","family":"Elm","sequence":"first","affiliation":[{"name":"Department of Pathology, Nuremberg Clinic, Paracelsus Medical University, 90419 Nuremberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1398-178X","authenticated-orcid":false,"given":"Georgia","family":"Levidou","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nuremberg Clinic, Paracelsus Medical University, 90419 Nuremberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,26]]},"reference":[{"key":"ref_1","unstructured":"(2023, October 24). Thymoma Workup. Available online: https:\/\/emedicine.medscape.com\/article\/193809-overview?form=fpf."},{"key":"ref_2","unstructured":"(2023, October 24). Thymoma (Thymic Carcinoma). Available online: https:\/\/my.clevelandclinic.org\/health\/diseases\/6196-thymoma-and-thymic-carcinoma."},{"key":"ref_3","unstructured":"(2023, October 24). Thymoma and Thymic Carcinoma Treatment (PDQ\u00ae), Available online: https:\/\/www.cancer.gov\/types\/thymoma\/hp\/thymoma-treatment-pdq."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Petrini, I., Rajan, A., Pham, T., Voeller, D., Davis, S., Gao, J., Wang, Y., and Giaccone, G. (2013). Whole Genome and Transcriptome Sequencing of a B3 Thymoma. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060572"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1016\/j.cllc.2021.07.008","article-title":"PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients","volume":"23","author":"Remon","year":"2022","journal-title":"Clin. Lung Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.21037\/jtd-2019-thym-13","article-title":"Correlation of genomic alterations and PD-L1 expression in thymoma","volume":"12","author":"Jovanovic","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1158\/1538-7445.AM2019-1705","article-title":"Abstract 1705: Genetic analysis of thymoma and thymic carcinoma","volume":"79","author":"Yamaguchi","year":"2019","journal-title":"Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.31557\/APJCP.2022.23.1.109","article-title":"TP53 and EGFR Mutational Status in Thymoma: A Genetic Sequencing Study","volume":"23","author":"Syahruddin","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s12253-016-0144-8","article-title":"Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets","volume":"23","author":"Enkner","year":"2017","journal-title":"Pathol. Oncol. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1038\/oncsis.2014.25","article-title":"ASXL1 and DNMT3A mutation in a cytogenetically normal B3 thymoma","volume":"3","author":"Belani","year":"2014","journal-title":"Oncogenesis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.21037\/tlcr-22-794","article-title":"Genetic profile of thymic epithelial tumors in the Japanese population: An exploratory study examining potential therapeutic targets","volume":"12","author":"Shimada","year":"2023","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.21037\/jtd.2019.12.52","article-title":"Genomic alterations in thymoma\u2014Molecular pathogenesis?","volume":"12","author":"Oberndorfer","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hsieh, M.-S., Kao, H.-L., Huang, W.-C., Wang, S.-Y., Lin, S.-Y., Chu, P.-Y., Pan, C.-C., Chou, T.-Y., Ho, H.-L., and Yeh, Y.-C. (2023). Constant p.L424H Mutation in GTF2I in Micronodular Thymomas with Lymphoid Stroma: Evidence Supporting Close Relationship with Type A and AB Thymomas. Mod. Pathol., 36.","DOI":"10.21203\/rs.3.rs-1747099\/v1"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2478\/raon-2023-0013","article-title":"Molecular profiling of rare thymoma using next-generation sequencing: Meta-analysis","volume":"57","author":"Cirkovic","year":"2023","journal-title":"Radiol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/carcin\/bgx094","article-title":"The genomic and epigenomic landscape in thymic carcinoma","volume":"38","author":"Saito","year":"2017","journal-title":"Carcinogenesis"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Szpechcinski, A., Szolkowska, M., Winiarski, S., Lechowicz, U., Wisniewski, P., and Knetki-Wroblewska, M. (2022). Targeted Next-Generation Sequencing of Thymic Epithelial Tumours Revealed Pathogenic Variants in KIT, ERBB2, KRAS, and TP53 in 30% of Thymic Carcinomas. Cancers, 14.","DOI":"10.3390\/cancers14143388"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ng.3016","article-title":"A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors","volume":"46","author":"Petrini","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Okuda, K., Moriyama, S., Haneda, H., Kawano, O., and Nakanishi, R. (2017). Specific mutations in thymic epithelial tumors. Mediastinum, 1.","DOI":"10.21037\/med.2017.10.07"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.jtho.2016.04.013","article-title":"PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors","volume":"11","author":"Alberobello","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"10575","DOI":"10.1002\/cam4.5795","article-title":"Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes","volume":"12","author":"Yang","year":"2023","journal-title":"Cancer Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.21037\/atm-21-5182","article-title":"Characteristics of genomic mutations and signaling pathway alterations in thymic epithelial tumors","volume":"9","author":"Yang","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2237040","DOI":"10.1080\/07853890.2023.2237040","article-title":"Significance of YAP1\u2013MAML2 rearrangement and GTF2I mutation in the diagnosis and differential diagnosis of metaplastic thymoma","volume":"55","author":"Wang","year":"2023","journal-title":"Ann. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1038\/srep07336","article-title":"Mutations of epigenetic regulatory genes are common in thymic carcinomas","volume":"4","author":"Wang","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/his.15024","article-title":"Loss of YAP1 C-terminus expression as an ancillary marker for metaplastic thymoma: A potential pitfall in detecting YAP1::MAML2 gene rearrangement","volume":"83","author":"Wang","year":"2023","journal-title":"Histopathology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41379-019-0382-x","article-title":"Metaplastic thymoma: A distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions","volume":"33","author":"Vivero","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e929727-1","DOI":"10.12659\/MSM.929727","article-title":"Identification and Characterization of Non-Coding RNAs in Thymoma","volume":"27","author":"Ji","year":"2021","journal-title":"Med. Sci. Monit."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1200\/PO.19.00288","article-title":"Pan-Cancer Landscape Analysis Reveals Recurrent KMT2A-MAML2 Gene Fusion in Aggressive Histologic Subtypes of Thymoma","volume":"4","author":"Massoth","year":"2020","journal-title":"JCO Precis. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.18632\/aging.204108","article-title":"A novel immune-related microRNA signature for prognosis of thymoma","volume":"14","author":"Wang","year":"2022","journal-title":"Aging"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/bjc.2015.425","article-title":"A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas","volume":"114","author":"Radovich","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1038\/s41598-019-38878-z","article-title":"Genetic characterization of thymoma","volume":"9","author":"Yu","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"v754","DOI":"10.1093\/annonc\/mdz266.017","article-title":"Transcriptomic difference of thymoma and thymic carcinoma","volume":"30","author":"Liang","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/1759-7714.13873","article-title":"Identification of differentially expressed circular RNAs associated with thymoma","volume":"12","author":"Wu","year":"2021","journal-title":"Thorac. Cancer"},{"key":"ref_33","first-page":"2413","article-title":"Expression of molecules of the Wnt pathway and of E-cadherin in the etiopathogenesis of human thymomas","volume":"19","author":"Vodicka","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.21037\/jtd.2019.06.01","article-title":"The Cancer Genome Atlas dataset-based analysis of aberrantly expressed genes by GeneAnalytics in thymoma associated myasthenia gravis: Focusing on T cells","volume":"11","author":"Xi","year":"2019","journal-title":"J. Thorac. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Xin, Y., Cai, H., Lu, T., Zhang, Y., Yang, Y., and Cui, Y. (2016). miR-20b Inhibits T Cell Proliferation and Activation via NFAT Signaling Pathway in Thymoma-Associated Myasthenia Gravis. BioMed Res. Int., 2016.","DOI":"10.1155\/2016\/9595718"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"G\u00f6kmen-Polar, Y., Cook, R.W., Goswami, C.P., Wilkinson, J., Maetzold, D., Stone, J.F., Oelschlager, K.M., Vladislav, I.T., Shirar, K.L., and Kesler, K.A. (2013). A Gene Signature to Determine Metastatic Behavior in Thymomas. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066047"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0022-4804(02)00040-9","article-title":"Clinical significance of tissue inhibitor of metalloproteinase and matrix metalloproteinase mRNA expression in thymoma","volume":"109","author":"Yukiue","year":"2003","journal-title":"J. Surg. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","article-title":"The Integrated Genomic Landscape of Thymic Epithelial Tumors","volume":"33","author":"Radovich","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lloyd, S.M., and Bao, X. (2019). Pinpointing the Genomic Localizations of Chromatin-Associated Proteins: The Yesterday, Today, and Tomorrow of ChIP-seq. Curr. Protoc. Cell Biol., 84.","DOI":"10.1002\/cpcb.89"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"708735","DOI":"10.3389\/fonc.2021.708735","article-title":"Diagnostic and Prognostic Significances of SOX9 in Thymic Epithelial Tumor","volume":"11","author":"Yuan","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Nicol\u00ec, V., and Copped\u00e8, F. (2023). Epigenetics of Thymic Epithelial Tumors. Cancers, 15.","DOI":"10.3390\/cancers15020360"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13148-019-0619-z","article-title":"Discovery and validation of DNA methylation markers for overall survival prognosis in patients with thymic epithelial tumors","volume":"11","author":"Li","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1097\/JTO.0000000000000298","article-title":"State of the Art of Genetic Alterations in Thymic Epithelial Tumors","volume":"9","author":"Rajan","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.lungcan.2008.07.015","article-title":"Aberrant methylation of tumour-related genes in thymic epithelial tumours","volume":"64","author":"Hirose","year":"2009","journal-title":"Lung Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/07357900802620869","article-title":"Aberrant DNA Methylation in Thymic Epithelial Tumors","volume":"27","author":"Chen","year":"2009","journal-title":"Cancer Investigation"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jtho.2019.08.666","article-title":"MA20.03 DNA Methylation of MT1A and NPTX2 Genes Predict Malignant Behavior of Thymic Epithelial Tumors","volume":"14","author":"Muguruma","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"ref_47","first-page":"2762","article-title":"Genome-wide DNA methylation profile of thymomas and potential epigenetic regulation of thymoma subtypes","volume":"41","author":"Bi","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Gaiser, T., Hirsch, D., Porth, I., Sahm, F., Str\u00f6bel, P., von Deimling, A., and Marx, A. (2022). DNA-Methylation Analysis as a Tool for Thymoma Classification. Cancers, 14.","DOI":"10.3390\/cancers14235876"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1111\/1759-7714.14628","article-title":"Promotor methylation status of MAPK4 is a novel epigenetic biomarker for prognosis of recurrence in patients with thymic epithelial tumors","volume":"13","author":"Guan","year":"2022","journal-title":"Thorac. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1158\/1078-0432.CCR-12-3260","article-title":"Copy Number Aberrations of Genes Regulating Normal Thymus Development in Thymic Epithelial Tumors","volume":"19","author":"Petrini","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0002-9440(10)64426-4","article-title":"Chromosome 6 Suffers Frequent and Multiple Aberrations in Thymoma","volume":"161","author":"Inoue","year":"2002","journal-title":"Am. J. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Lee, G.Y., Yang, W.I., Jeung, H.C., Kim, S.C., Seo, M.Y., Park, C.H., Chung, H.C., and Rha, S.Y. (2007). Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization. BMC Genom., 8.","DOI":"10.1186\/1471-2164-8-305"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1038\/cddis.2012.92","article-title":"Copy number aberrations of BCL2 and CDKN2A\/B identified by array-CGH in thymic epithelial tumors","volume":"3","author":"Petrini","year":"2012","journal-title":"Cell Death Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.semdp.2021.06.011","article-title":"Molecular landscape of thymic epithelial tumors","volume":"39","author":"Prays","year":"2022","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Liu, D., Zhang, P., Zhao, J., Yang, L., and Wang, W. (2021). Identification of Molecular Characteristics and New Prognostic Targets for Thymoma by Multiomics Analysis. BioMed Res. Int., 2021.","DOI":"10.1155\/2021\/5587441"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/1759-7714.13053","article-title":"Alteration in gene expression profiles of thymoma: Genetic differences and potential novel targets","volume":"10","author":"Meng","year":"2019","journal-title":"Thorac. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00432-018-2770-x","article-title":"A novel prognostic signature of seven genes for the prediction in patients with thymoma","volume":"145","author":"Li","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Lai, L.-C., Sun, Q.-L., Chen, Y.-A., Hsiao, Y.-W., Lu, T.-P., Tsai, M.-H., Zhu, L., Chuang, E.Y., and Fang, W. (2019). Using proteomic profiling to characterize protein signatures of different thymoma subtypes. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-6023-4"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Badve, S., Goswami, C., G\u00f6kmen\u2013Polar, Y., Nelson, R.P., Henley, J., Miller, N., Zaheer, N.A., Sledge, G.W., Li, L., and Kesler, K.A. (2012). Molecular Analysis of Thymoma. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042669"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Tateo, V., Manuzzi, L., Parisi, C., De Giglio, A., Campana, D., Pantaleo, M.A., and Lamberti, G. (2021). An Overview on Molecular Characterization of Thymic Tumors: Old and New Targets for Clinical Advances. Pharmaceuticals, 14.","DOI":"10.3390\/ph14040316"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cllc.2020.11.010","article-title":"Mutation Profile of Thymic Carcinoma and Thymic Neuroendocrine Tumor by Targeted Next-generation Sequencing","volume":"22","author":"Sakane","year":"2021","journal-title":"Clin. Lung Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Psilopatis, I., Pergaris, A., Vrettou, K., Theocharis, S., and Troungos, C. (2022). Thymic Epithelial Neoplasms: Focusing on the Epigenetic Alterations. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23074045"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Maury, J.-M., Merveilleux du Vignaux, C., Drevet, G., Zarza, V., Chalabreysse, L., Maisse, C., Gineys, B., Dolmazon, C., Tronc, F., and Girard, N. (2019). Activation of the mTOR\/Akt pathway in thymic epithelial cells derived from thymomas. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0197655"},{"key":"ref_65","first-page":"e2200465","article-title":"Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors","volume":"7","author":"Schneider","year":"2023","journal-title":"JCO Precis. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/his.13936","article-title":"A mutation analysis of the EGFR pathway genes, RAS, EGFR, PIK3CA, AKT1 and BRAF, and TP53 gene in thymic carcinoma and thymoma type A\/B3","volume":"75","author":"Sakane","year":"2019","journal-title":"Histopathology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1158\/1078-0432.CCR-09-0644","article-title":"Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and Thymomas","volume":"15","author":"Girard","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1002\/cncr.25367","article-title":"Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas","volume":"116","author":"Zucali","year":"2010","journal-title":"Cancer"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1097\/JTO.0b013e3181f209b9","article-title":"Thymic Tumors: Relevant Molecular Data in the Clinic","volume":"5","author":"Girard","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/1759-7714.13486","article-title":"High expression of KITLG is a new hallmark activating the MAPK pathway in type A and AB thymoma","volume":"11","author":"Yang","year":"2020","journal-title":"Thorac. Cancer"},{"key":"ref_71","first-page":"669","article-title":"GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarray","volume":"35","author":"Riess","year":"2015","journal-title":"Anticancer Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1101\/gad.1686208","article-title":"Deciphering the function of canonical Wnt signals in development and disease: Conditional loss- and gain-of-function mutations of \u03b2-catenin in mice","volume":"22","author":"Grigoryan","year":"2008","journal-title":"Genes Dev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrclinonc.2010.196","article-title":"Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways","volume":"8","author":"Takebe","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Kumar, V., Vashishta, M., Kong, L., Wu, X., Lu, J.J., Guha, C., and Dwarakanath, B.S. (2021). The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.650772"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.21037\/jtd.2017.05.28","article-title":"Decreased Wnt4 expression inhibits thymoma development through downregulation of FoxN1","volume":"9","author":"Chen","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.4049\/jimmunol.0713723","article-title":"Stabilized \u03b2-Catenin in Thymic Epithelial Cells Blocks Thymus Development and Function1","volume":"182","author":"Zuklys","year":"2009","journal-title":"J. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1002\/eji.200323564","article-title":"Thymic epithelial cells provide Wnt signals to developing thymocytes","volume":"33","author":"Pongracz","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3389\/fimmu.2020.00664","article-title":"Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes","volume":"11","author":"Yamada","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jtho.2022.07.135","article-title":"MA10.08 Activated Pathways of Myastenia Gravis in Thymic Epithelial (TETs)","volume":"17","author":"Job","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Tanaka, T., Goto, Y., Horie, M., Masuda, K., Shinno, Y., Matsumoto, Y., Okuma, Y., Yoshida, T., Horinouchi, H., and Motoi, N. (2023). Whole Exome Sequencing of Thymoma Patients Exhibiting Exceptional Responses to Pemetrexed Monotherapy. Cancers, 15.","DOI":"10.3390\/cancers15164018"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1634\/theoncologist.2019-0393","article-title":"Metastatic Thymoma Harboring a Deleterious BRCA2 Mutation Derives Durable Clinical Benefit from Olaparib","volume":"25","author":"Principe","year":"2020","journal-title":"Oncologist"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Palamaris, K., Levidou, G., Kordali, K., Masaoutis, C., Rontogianni, D., and Theocharis, S. (2023). Searching for Novel Biomarkers in Thymic Epithelial Tumors: Immunohistochemical Evaluation of Hippo Pathway Components in a Cohort of Thymic Epithelial Tumors. Biomedicines, 11.","DOI":"10.3390\/biomedicines11071876"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1309\/AJCP76KEGWQKWOKA","article-title":"Thymomas I: A Clinicopathologic Correlation of 250 Cases with Emphasis on the World Health Organization Schema","volume":"137","author":"Moran","year":"2012","journal-title":"Am. J. Clin. Pathol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/3\/1554\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:49:57Z","timestamp":1760104197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/3\/1554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,26]]},"references-count":83,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["ijms25031554"],"URL":"https:\/\/doi.org\/10.3390\/ijms25031554","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,26]]}}}